IRONWOOD PHARMACEUTICALS INC
IRWD
Transaktioner
719
Köp
378
Sälj
341
Nettoinsynsflöde
-26.7 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
719 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-07-20 | Silber Jeffrey | SVP, CMO, Head-Res&Drug | Buy | 137 k | 0,00 | 0 USD |
| 2026-07-20 | Silber Jeffrey | SVP, CMO, Head-Res&Drug | Buy | 137 k | 0,00 | 0 USD |
| 2026-07-07 | Silver Ronald | PFO & PAO | Sell | 128 k | 4,52 | 578 k USD |
| 2026-07-07 | Silver Ronald | PFO & PAO | Sell | 128 k | 4,52 | 578 k USD |
| 2026-06-16 | Currie Mark G | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | DENNER ALEXANDER J | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | Duane Jon R | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | Moukheibir Catherine | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | McHugh Julie | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | McHugh Julie | Director | Sell | 22 k | 3,73 | 80 k USD |
| 2026-06-16 | DENNER ALEXANDER J | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | Duane Jon R | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | Currie Mark G | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | Kessler Marla L | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | Shepard Jay | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | Kessler Marla L | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | McHugh Julie | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | McHugh Julie | Director | Sell | 22 k | 3,73 | 80 k USD |
| 2026-06-16 | Moukheibir Catherine | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-16 | Shepard Jay | Director | Buy | 63 k | 0,00 | 0 USD |
| 2026-06-15 | DENNER ALEXANDER J | Director | Buy | 4 k | 0,00 | 0 USD |
| 2026-06-15 | DENNER ALEXANDER J | Director | Buy | 4 k | 0,00 | 0 USD |
| 2026-05-19 | Silver Ronald | PFO & PAO | Buy | 25 k | 0,00 | 0 USD |
| 2026-05-19 | Silver Ronald | PFO & PAO | Buy | 25 k | 0,00 | 0 USD |
| 2026-03-17 | DENNER ALEXANDER J | Director | Sell | 6.7 mn | 3,05 | 20.5 mn USD |
| 2026-03-17 | DENNER ALEXANDER J | Director | Sell | 6 k | 3,31 | 19 k USD |
| 2026-03-17 | DENNER ALEXANDER J | Director | Sell | 6.7 mn | 3,05 | 20.5 mn USD |
| 2026-03-17 | DENNER ALEXANDER J | Director | Sell | 6 k | 3,31 | 19 k USD |
| 2026-03-13 | DENNER ALEXANDER J | Director | Buy | 4 k | 0,00 | 0 USD |
| 2026-03-13 | DENNER ALEXANDER J | Director | Buy | 4 k | 0,00 | 0 USD |
| 2026-03-10 | Gaskins Tammi L | Chief Commercial Officer | Buy | 137 k | 0,00 | 0 USD |
| 2026-03-10 | MCCOURT Thomas A | Chief Executive Officer | Buy | 410 k | 0,00 | 0 USD |
| 2026-03-10 | Martini Gregory S. | Chief Financial Officer | Buy | 137 k | 0,00 | 0 USD |
| 2026-03-10 | John Minardo | Chief Legal Officer | Buy | 137 k | 0,00 | 0 USD |
| 2026-03-10 | Silver Ronald | Principal Accounting Officer | Buy | 164 k | 0,00 | 0 USD |
| 2026-03-10 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Buy | 137 k | 0,00 | 0 USD |
| 2026-03-10 | Gaskins Tammi L | Chief Commercial Officer | Buy | 137 k | 0,00 | 0 USD |
| 2026-03-10 | John Minardo | Chief Legal Officer | Buy | 137 k | 0,00 | 0 USD |
| 2026-03-10 | MCCOURT Thomas A | Chief Executive Officer | Buy | 410 k | 0,00 | 0 USD |
| 2026-03-10 | Martini Gregory S. | Chief Financial Officer | Buy | 137 k | 0,00 | 0 USD |
| 2026-03-10 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Buy | 137 k | 0,00 | 0 USD |
| 2026-03-10 | Silver Ronald | Principal Accounting Officer | Buy | 164 k | 0,00 | 0 USD |
| 2026-02-24 | Gaskins Tammi L | Chief Commercial Officer | Sell | 11 k | 3,66 | 41 k USD |
| 2026-02-24 | Silver Ronald | Principal Accounting Officer | Sell | 13 k | 3,66 | 46 k USD |
| 2026-02-24 | MCCOURT Thomas A | Chief Executive Officer | Sell | 104 k | 3,66 | 379 k USD |
| 2026-02-24 | Gaskins Tammi L | Chief Commercial Officer | Sell | 11 k | 3,66 | 41 k USD |
| 2026-02-24 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell | 17 k | 3,66 | 62 k USD |
| 2026-02-24 | John Minardo | Chief Legal Officer | Sell | 19 k | 3,66 | 70 k USD |
| 2026-02-24 | Martini Gregory S. | Chief Financial Officer | Sell | 11 k | 3,66 | 42 k USD |
| 2026-02-24 | John Minardo | Chief Legal Officer | Sell | 19 k | 3,66 | 70 k USD |
| 2026-02-24 | MCCOURT Thomas A | Chief Executive Officer | Sell | 104 k | 3,66 | 379 k USD |
| 2026-02-24 | Martini Gregory S. | Chief Financial Officer | Sell | 11 k | 3,66 | 42 k USD |
| 2026-02-24 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell | 17 k | 3,66 | 62 k USD |
| 2026-02-24 | Silver Ronald | Principal Accounting Officer | Sell | 13 k | 3,66 | 46 k USD |
| 2026-02-23 | Gaskins Tammi L | Chief Commercial Officer | Sell | 10 k | 3,81 | 39 k USD |
| 2026-02-23 | Silver Ronald | Principal Accounting Officer | Sell | 12 k | 3,81 | 44 k USD |
| 2026-02-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 95 k | 3,81 | 361 k USD |
| 2026-02-23 | Gaskins Tammi L | Chief Commercial Officer | Sell | 10 k | 3,81 | 39 k USD |
| 2026-02-23 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell | 16 k | 3,81 | 59 k USD |
| 2026-02-23 | John Minardo | Chief Legal Officer | Sell | 17 k | 3,81 | 66 k USD |
| 2026-02-23 | Martini Gregory S. | Chief Financial Officer | Sell | 10 k | 3,81 | 40 k USD |
| 2026-02-23 | John Minardo | Chief Legal Officer | Sell | 17 k | 3,81 | 66 k USD |
| 2026-02-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 95 k | 3,81 | 361 k USD |
| 2026-02-23 | Martini Gregory S. | Chief Financial Officer | Sell | 10 k | 3,81 | 40 k USD |
| 2026-02-23 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell | 16 k | 3,81 | 59 k USD |
| 2026-02-23 | Silver Ronald | Principal Accounting Officer | Sell | 12 k | 3,81 | 44 k USD |
| 2026-01-05 | Silver Ronald | Principal Accounting Officer | Sell | 35 k | 4,60 | 163 k USD |
| 2026-01-05 | Silver Ronald | Principal Accounting Officer | Sell | 35 k | 4,60 | 163 k USD |
| 2025-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 4 k | 0,00 | 0 USD |
| 2025-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 4 k | 0,00 | 0 USD |
| 2025-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 4 k | 0,00 | 0 USD |
| 2025-11-17 | Gaskins Tammi L | Chief Commercial Officer | Sell | 6 k | 3,32 | 20 k USD |
| 2025-11-17 | Gaskins Tammi L | Chief Commercial Officer | Sell | 6 k | 3,32 | 20 k USD |
| 2025-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 12 k | 0,00 | 0 USD |
| 2025-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 12 k | 0,00 | 0 USD |
| 2025-08-11 | Gaskins Tammi L | Chief Commercial Officer | Sell | 1 k | 0,84 | 1 k USD |
| 2025-08-11 | Martini Gregory S. | Chief Financial Officer | Sell | 1 k | 0,84 | 1 k USD |
| 2025-08-11 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 0,84 | 2 k USD |
| 2025-08-11 | John Minardo | Chief Legal Officer | Sell | 8 k | 0,84 | 7 k USD |
| 2025-08-11 | Gaskins Tammi L | Chief Commercial Officer | Sell | 1 k | 0,84 | 1 k USD |
| 2025-08-11 | John Minardo | Chief Legal Officer | Sell | 8 k | 0,84 | 7 k USD |
| 2025-08-11 | Martini Gregory S. | Chief Financial Officer | Sell | 1 k | 0,84 | 1 k USD |
| 2025-08-11 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 0,84 | 2 k USD |
| 2025-06-13 | DENNER ALEXANDER J | Director, 10% owner | Buy | 24 k | 0,00 | 0 USD |
| 2025-06-13 | DENNER ALEXANDER J | Director, 10% owner | Buy | 24 k | 0,00 | 0 USD |
| 2025-06-13 | DENNER ALEXANDER J | Director, 10% owner | Buy | 24 k | 0,00 | 0 USD |
| 2025-06-10 | Currie Mark G | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Dreyfus Andrew | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Duane Jon R | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | DENNER ALEXANDER J | Director, 10% owner | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Dreyfus Andrew | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | McHugh Julie | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Currie Mark G | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Duane Jon R | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Moukheibir Catherine | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Shepard Jay | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Kessler Marla L | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Kessler Marla L | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | McHugh Julie | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Moukheibir Catherine | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | DENNER ALEXANDER J | Director, 10% owner | Buy | 45 k | 0,00 | 0 USD |
| 2025-06-10 | Shepard Jay | Director | Buy | 45 k | 0,00 | 0 USD |
| 2025-05-20 | MCCOURT Thomas A | Chief Executive Officer | Buy | 540 k | 0,00 | 0 USD |
| 2025-05-20 | MCCOURT Thomas A | Chief Executive Officer | Buy | 540 k | 0,00 | 0 USD |
| 2025-05-16 | Gaskins Tammi L | Chief Commercial Officer | Sell | 3 k | 0,58 | 1 k USD |
| 2025-05-16 | Gaskins Tammi L | Chief Commercial Officer | Sell | 3 k | 0,58 | 1 k USD |
| 2025-05-16 | MCCOURT Thomas A | Chief Executive Officer | Sell | 13 k | 0,58 | 8 k USD |
| 2025-05-16 | MCCOURT Thomas A | Chief Executive Officer | Sell | 13 k | 0,58 | 8 k USD |
| 2025-04-02 | DENNER ALEXANDER J | Director, 10% owner | Buy | 10 k | 0,00 | 0 USD |
| 2025-04-02 | DENNER ALEXANDER J | Director, 10% owner | Buy | 10 k | 0,00 | 0 USD |
| 2025-04-02 | DENNER ALEXANDER J | Director, 10% owner | Buy | 10 k | 0,00 | 0 USD |
| 2025-02-10 | Martini Gregory S. | Chief Financial Officer | Sell | 12 k | 1,76 | 21 k USD |
| 2025-02-10 | John Minardo | Chief Legal Officer | Buy | 122 k | 0,00 | 0 USD |
| 2025-02-10 | John Minardo | Chief Legal Officer | Sell | 39 k | 1,76 | 69 k USD |
| 2025-02-10 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Buy | 133 k | 0,00 | 0 USD |
| 2025-02-10 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell | 41 k | 1,76 | 73 k USD |
| 2025-02-10 | Silver Ronald | Principal Accounting Officer | Sell | 12 k | 1,76 | 21 k USD |
| 2025-02-10 | MCCOURT Thomas A | Chief Executive Officer | Sell | 139 k | 1,76 | 245 k USD |
| 2025-02-10 | John Minardo | Chief Legal Officer | Buy | 122 k | 0,00 | 0 USD |
| 2025-02-10 | John Minardo | Chief Legal Officer | Sell | 39 k | 1,76 | 69 k USD |
| 2025-02-10 | MCCOURT Thomas A | Chief Executive Officer | Sell | 139 k | 1,76 | 245 k USD |
| 2025-02-10 | Martini Gregory S. | Chief Financial Officer | Sell | 12 k | 1,76 | 21 k USD |
| 2025-02-10 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Buy | 133 k | 0,00 | 0 USD |
| 2025-02-10 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell | 41 k | 1,76 | 73 k USD |
| 2025-02-10 | Silver Ronald | Principal Accounting Officer | Sell | 12 k | 1,76 | 21 k USD |
| 2025-01-27 | Martini Gregory S. | Chief Financial Officer | Buy | 111 k | 0,00 | 0 USD |
| 2025-01-27 | Silver Ronald | Principal Accounting Officer | Buy | 133 k | 0,00 | 0 USD |
| 2025-01-27 | Martini Gregory S. | Chief Financial Officer | Buy | 111 k | 0,00 | 0 USD |
| 2025-01-27 | Silver Ronald | Principal Accounting Officer | Buy | 133 k | 0,00 | 0 USD |
| 2025-01-17 | MCCOURT Thomas A | Chief Executive Officer | Buy | 147 k | 0,00 | 0 USD |
| 2025-01-17 | John Minardo | Chief Legal Officer | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-17 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Buy | 48 k | 0,00 | 0 USD |
| 2025-01-17 | John Minardo | Chief Legal Officer | Buy | 40 k | 0,00 | 0 USD |
| 2025-01-17 | MCCOURT Thomas A | Chief Executive Officer | Buy | 147 k | 0,00 | 0 USD |
| 2025-01-17 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Buy | 48 k | 0,00 | 0 USD |
| 2024-12-16 | DENNER ALEXANDER J | Director, 10% owner | Buy | 4 k | 0,00 | 0 USD |
| 2024-12-16 | DENNER ALEXANDER J | Director, 10% owner | Buy | 4 k | 0,00 | 0 USD |
| 2024-12-16 | DENNER ALEXANDER J | Director, 10% owner | Buy | 4 k | 0,00 | 0 USD |
| 2024-11-18 | Davis Andrew | SVP, Chief Business Officer | Sell | 5 k | 4,08 | 22 k USD |
| 2024-11-18 | Emany Sravan Kumar | SVP, COO and CFO | Sell | 11 k | 4,08 | 45 k USD |
| 2024-11-18 | Emany Sravan Kumar | SVP, COO and CFO | Sell | 11 k | 4,08 | 45 k USD |
| 2024-11-18 | Davis Andrew | SVP, Chief Business Officer | Sell | 5 k | 4,08 | 22 k USD |
| 2024-09-16 | DENNER ALEXANDER J | Director, 10% owner | Buy | 3 k | 0,00 | 0 USD |
| 2024-09-16 | DENNER ALEXANDER J | Director, 10% owner | Buy | 3 k | 0,00 | 0 USD |
| 2024-09-16 | DENNER ALEXANDER J | Director, 10% owner | Buy | 3 k | 0,00 | 0 USD |
| 2024-08-12 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 4,27 | 13 k USD |
| 2024-08-12 | John Minardo | Chief Legal Officer | Sell | 10 k | 4,27 | 42 k USD |
| 2024-08-12 | John Minardo | Chief Legal Officer | Sell | 10 k | 4,27 | 42 k USD |
| 2024-08-12 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 4,27 | 13 k USD |
| 2024-06-18 | Currie Mark G | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | DENNER ALEXANDER J | Director, 10% owner | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Dreyfus Andrew | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Duane Jon R | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Currie Mark G | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Kessler Marla L | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Duane Jon R | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | McHugh Julie | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Dreyfus Andrew | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Shepard Jay | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | DENNER ALEXANDER J | Director, 10% owner | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Moukheibir Catherine | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Kessler Marla L | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | McHugh Julie | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Moukheibir Catherine | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | DENNER ALEXANDER J | Director, 10% owner | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-18 | Shepard Jay | Director | Buy | 24 k | 0,00 | 0 USD |
| 2024-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 3 k | 0,00 | 0 USD |
| 2024-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 3 k | 0,00 | 0 USD |
| 2024-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 3 k | 0,00 | 0 USD |
| 2024-06-10 | McHugh Julie | Director | Sell | 23 k | 6,29 | 143 k USD |
| 2024-06-10 | McHugh Julie | Director | Sell | 23 k | 6,29 | 143 k USD |
| 2024-06-07 | Moukheibir Catherine | Director | Sell | 36 k | 6,61 | 235 k USD |
| 2024-06-07 | Moukheibir Catherine | Director | Sell | 36 k | 6,61 | 235 k USD |
| 2024-06-06 | Moukheibir Catherine | Director | Sell | 44 k | 6,36 | 283 k USD |
| 2024-06-06 | Moukheibir Catherine | Director | Sell | 44 k | 6,36 | 283 k USD |
| 2024-05-20 | Davis Andrew | SVP, Chief Business Officer | Sell | 23 k | 6,45 | 147 k USD |
| 2024-05-20 | John Minardo | Chief Legal Officer | Sell | 17 k | 6,45 | 112 k USD |
| 2024-05-20 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 16 k | 6,45 | 104 k USD |
| 2024-05-20 | Davis Andrew | SVP, Chief Business Officer | Sell | 23 k | 6,45 | 147 k USD |
| 2024-05-20 | MCCOURT Thomas A | Chief Executive Officer | Sell | 68 k | 6,45 | 436 k USD |
| 2024-05-20 | John Minardo | Chief Legal Officer | Sell | 17 k | 6,45 | 112 k USD |
| 2024-05-20 | MCCOURT Thomas A | Chief Executive Officer | Sell | 68 k | 6,45 | 436 k USD |
| 2024-05-20 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 16 k | 6,45 | 104 k USD |
| 2024-05-16 | Emany Sravan Kumar | SVP, Chief Financial Officer | Sell | 18 k | 6,64 | 121 k USD |
| 2024-05-16 | Emany Sravan Kumar | SVP, Chief Financial Officer | Sell | 18 k | 6,64 | 121 k USD |
| 2024-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 2 k | 0,00 | 0 USD |
| 2024-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 2 k | 0,00 | 0 USD |
| 2024-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 2 k | 0,00 | 0 USD |
| 2024-03-08 | Davis Andrew | SVP, Chief Business Officer | Buy | 37 k | 0,00 | 0 USD |
| 2024-03-08 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 37 k | 0,00 | 0 USD |
| 2024-03-08 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 35 k | 0,00 | 0 USD |
| 2024-03-08 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 37 k | 0,00 | 0 USD |
| 2024-03-08 | John Minardo | Chief Legal Officer | Buy | 33 k | 0,00 | 0 USD |
| 2024-03-08 | MCCOURT Thomas A | Chief Executive Officer | Buy | 120 k | 0,00 | 0 USD |
| 2024-03-08 | Davis Andrew | SVP, Chief Business Officer | Buy | 37 k | 0,00 | 0 USD |
| 2024-03-08 | John Minardo | Chief Legal Officer | Buy | 33 k | 0,00 | 0 USD |
| 2024-03-08 | MCCOURT Thomas A | Chief Executive Officer | Buy | 120 k | 0,00 | 0 USD |
| 2024-03-08 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 35 k | 0,00 | 0 USD |
| 2024-03-06 | Duane Jon R | Director | Buy | 7 k | 8,70 | 60 k USD |
| 2024-03-06 | Duane Jon R | Director | Buy | 7 k | 8,70 | 60 k USD |
| 2024-03-05 | MCCOURT Thomas A | Chief Executive Officer | Buy | 265 k | 0,00 | 0 USD |
| 2024-03-05 | MCCOURT Thomas A | Chief Executive Officer | Buy | 265 k | 0,00 | 0 USD |
| 2024-03-04 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 11 k | 9,38 | 100 k USD |
| 2024-03-04 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 11 k | 9,38 | 100 k USD |
| 2024-02-12 | Davis Andrew | SVP, Chief Business Officer | Sell | 10 k | 15,24 | 150 k USD |
| 2024-02-12 | Davis Andrew | SVP, Chief Business Officer | Buy | 65 k | 0,00 | 0 USD |
| 2024-02-12 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 65 k | 0,00 | 0 USD |
| 2024-02-12 | MCCOURT Thomas A | Chief Executive Officer | Sell | 177 k | 15,24 | 2.7 mn USD |
| 2024-02-12 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 65 k | 0,00 | 0 USD |
| 2024-02-12 | Davis Andrew | SVP, Chief Business Officer | Sell | 10 k | 15,24 | 150 k USD |
| 2024-02-12 | Davis Andrew | SVP, Chief Business Officer | Buy | 65 k | 0,00 | 0 USD |
| 2024-02-12 | Silver Ronald | Principal Accounting Officer | Sell | 8 k | 15,24 | 121 k USD |
| 2024-02-12 | Silver Ronald | Principal Accounting Officer | Buy | 27 k | 0,00 | 0 USD |
| 2024-02-12 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 39 k | 15,24 | 589 k USD |
| 2024-02-12 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 54 k | 0,00 | 0 USD |
| 2024-02-12 | John Minardo | Chief Legal Officer | Sell | 47 k | 15,24 | 722 k USD |
| 2024-02-12 | John Minardo | Chief Legal Officer | Buy | 54 k | 0,00 | 0 USD |
| 2024-02-12 | John Minardo | Chief Legal Officer | Sell | 47 k | 15,24 | 722 k USD |
| 2024-02-12 | John Minardo | Chief Legal Officer | Buy | 54 k | 0,00 | 0 USD |
| 2024-02-12 | MCCOURT Thomas A | Chief Executive Officer | Sell | 177 k | 15,24 | 2.7 mn USD |
| 2024-02-12 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 39 k | 15,24 | 589 k USD |
| 2024-02-12 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 54 k | 0,00 | 0 USD |
| 2024-02-12 | Silver Ronald | Principal Accounting Officer | Sell | 8 k | 15,24 | 121 k USD |
| 2024-02-12 | Silver Ronald | Principal Accounting Officer | Buy | 27 k | 0,00 | 0 USD |
| 2024-02-08 | Emany Sravan Kumar | SVP, Chief Financial Officer | Sell | 41 k | 14,90 | 616 k USD |
| 2024-02-08 | Emany Sravan Kumar | SVP, Chief Financial Officer | Sell | 41 k | 14,90 | 616 k USD |
| 2024-01-17 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 85 k | 0,00 | 0 USD |
| 2024-01-17 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 85 k | 0,00 | 0 USD |
| 2024-01-17 | John Minardo | Chief Legal Officer | Buy | 80 k | 0,00 | 0 USD |
| 2024-01-17 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 58 k | 0,00 | 0 USD |
| 2024-01-17 | MCCOURT Thomas A | Chief Executive Officer | Buy | 250 k | 0,00 | 0 USD |
| 2024-01-17 | John Minardo | Chief Legal Officer | Buy | 80 k | 0,00 | 0 USD |
| 2024-01-17 | MCCOURT Thomas A | Chief Executive Officer | Buy | 250 k | 0,00 | 0 USD |
| 2024-01-17 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 58 k | 0,00 | 0 USD |
| 2023-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2023-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2023-12-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-12-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2023-12-14 | Kessler Marla L | Director | Sell | 10 k | 11,19 | 111 k USD |
| 2023-12-14 | Kessler Marla L | Director | Sell | 10 k | 11,19 | 111 k USD |
| 2023-11-20 | Davis Andrew | SVP, Chief Business Officer | Sell | 3 k | 9,69 | 32 k USD |
| 2023-11-20 | Davis Andrew | SVP, Chief Business Officer | Sell | 3 k | 9,69 | 32 k USD |
| 2023-11-16 | Emany Sravan Kumar | SVP, Chief Financial Officer | Sell | 7 k | 9,44 | 63 k USD |
| 2023-11-16 | Emany Sravan Kumar | SVP, Chief Financial Officer | Sell | 7 k | 9,44 | 63 k USD |
| 2023-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 2 k | 0,00 | 0 USD |
| 2023-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 2 k | 0,00 | 0 USD |
| 2023-09-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-09-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 2 k | 0,00 | 0 USD |
| 2023-09-15 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 36 k | 8,32 | 300 k USD |
| 2023-09-15 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 36 k | 8,32 | 300 k USD |
| 2023-08-29 | Silver Ronald | Principal Accounting Officer | Buy | 8 k | 0,00 | 0 USD |
| 2023-08-29 | Silver Ronald | Principal Accounting Officer | Buy | 8 k | 0,00 | 0 USD |
| 2023-08-14 | John Minardo | Chief Legal Officer | Sell | 7 k | 10,04 | 71 k USD |
| 2023-08-14 | Silver Ronald | Principal Accounting Officer | Sell | 2 k | 10,04 | 20 k USD |
| 2023-08-14 | John Minardo | Chief Legal Officer | Sell | 7 k | 10,04 | 71 k USD |
| 2023-08-14 | Silver Ronald | Principal Accounting Officer | Sell | 2 k | 10,04 | 20 k USD |
| 2023-06-20 | Currie Mark G | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | DENNER ALEXANDER J | Director, 10% owner | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Dreyfus Andrew | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Duane Jon R | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Currie Mark G | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | DENNER ALEXANDER J | Director, 10% owner | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Dreyfus Andrew | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Duane Jon R | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Kessler Marla L | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | McHugh Julie | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Moukheibir Catherine | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Shepard Jay | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Kessler Marla L | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | McHugh Julie | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Moukheibir Catherine | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | DENNER ALEXANDER J | Director, 10% owner | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-20 | Shepard Jay | Director | Buy | 22 k | 0,00 | 0 USD |
| 2023-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2023-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2023-06-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-06-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-30 | MCCOURT Thomas A | Chief Executive Officer | Sell | 27 k | 10,70 | 285 k USD |
| 2023-05-30 | MCCOURT Thomas A | Chief Executive Officer | Sell | 27 k | 10,70 | 285 k USD |
| 2023-05-22 | Davis Andrew | SVP, Chief Business Officer | Sell | 6 k | 10,12 | 64 k USD |
| 2023-05-22 | Davis Andrew | SVP, Chief Business Officer | Sell | 6 k | 10,12 | 64 k USD |
| 2023-05-22 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 10 k | 10,12 | 104 k USD |
| 2023-05-22 | MCCOURT Thomas A | Chief Executive Officer | Sell | 36 k | 10,12 | 364 k USD |
| 2023-05-22 | MCCOURT Thomas A | Chief Executive Officer | Sell | 36 k | 10,12 | 364 k USD |
| 2023-05-22 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 10 k | 10,12 | 104 k USD |
| 2023-05-08 | MCCOURT Thomas A | Chief Executive Officer | Sell | 21 k | 10,62 | 225 k USD |
| 2023-05-08 | MCCOURT Thomas A | Chief Executive Officer | Sell | 21 k | 10,62 | 225 k USD |
| 2023-03-27 | MCCOURT Thomas A | Chief Executive Officer | Sell | 46 k | 10,67 | 492 k USD |
| 2023-03-27 | MCCOURT Thomas A | Chief Executive Officer | Sell | 46 k | 10,67 | 492 k USD |
| 2023-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2023-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2023-03-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-03-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2023-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2023-03-08 | Davis Andrew | SVP, Chief Business Officer | Buy | 74 k | 0,00 | 0 USD |
| 2023-03-08 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 74 k | 0,00 | 0 USD |
| 2023-03-08 | Davis Andrew | SVP, Chief Business Officer | Buy | 74 k | 0,00 | 0 USD |
| 2023-03-08 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 74 k | 0,00 | 0 USD |
| 2023-03-08 | MCCOURT Thomas A | Chief Executive Officer | Buy | 241 k | 0,00 | 0 USD |
| 2023-03-08 | John Minardo | Chief Legal Officer | Buy | 66 k | 0,00 | 0 USD |
| 2023-03-08 | Rickard Jason | SVP, Chief Operating Officer | Buy | 44 k | 0,00 | 0 USD |
| 2023-03-08 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 70 k | 0,00 | 0 USD |
| 2023-03-08 | Silver Ronald | Principal Accounting Officer | Buy | 36 k | 0,00 | 0 USD |
| 2023-03-08 | John Minardo | Chief Legal Officer | Buy | 66 k | 0,00 | 0 USD |
| 2023-03-08 | MCCOURT Thomas A | Chief Executive Officer | Buy | 241 k | 0,00 | 0 USD |
| 2023-03-08 | Rickard Jason | SVP, Chief Operating Officer | Buy | 44 k | 0,00 | 0 USD |
| 2023-03-08 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 70 k | 0,00 | 0 USD |
| 2023-03-08 | Silver Ronald | Principal Accounting Officer | Buy | 36 k | 0,00 | 0 USD |
| 2023-03-03 | MCCOURT Thomas A | Chief Executive Officer | Sell | 34 k | 11,22 | 379 k USD |
| 2023-03-03 | MCCOURT Thomas A | Chief Executive Officer | Sell | 34 k | 11,22 | 379 k USD |
| 2023-02-28 | Davis Andrew | SVP, Chief Business Officer | Sell | 2 k | 11,31 | 21 k USD |
| 2023-02-28 | Davis Andrew | SVP, Chief Business Officer | Sell | 2 k | 11,31 | 21 k USD |
| 2023-02-28 | John Minardo | Chief Legal Officer | Sell | 3 k | 11,31 | 39 k USD |
| 2023-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 7 k | 11,31 | 84 k USD |
| 2023-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 2 k | 11,31 | 27 k USD |
| 2023-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 27 k | 11,31 | 301 k USD |
| 2023-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 5 k | 11,31 | 52 k USD |
| 2023-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 14 k | 11,31 | 158 k USD |
| 2023-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 11,31 | 39 k USD |
| 2023-02-28 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 11,31 | 34 k USD |
| 2023-02-28 | John Minardo | Chief Legal Officer | Sell | 3 k | 11,31 | 39 k USD |
| 2023-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 27 k | 11,31 | 301 k USD |
| 2023-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 5 k | 11,31 | 52 k USD |
| 2023-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 14 k | 11,31 | 158 k USD |
| 2023-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 11,31 | 39 k USD |
| 2023-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 7 k | 11,31 | 84 k USD |
| 2023-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 2 k | 11,31 | 27 k USD |
| 2023-02-28 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 11,31 | 34 k USD |
| 2023-02-27 | Davis Andrew | SVP, Chief Business Officer | Sell | 2 k | 11,41 | 20 k USD |
| 2023-02-27 | Davis Andrew | SVP, Chief Business Officer | Sell | 2 k | 11,41 | 20 k USD |
| 2023-02-27 | John Minardo | Chief Legal Officer | Sell | 3 k | 11,41 | 37 k USD |
| 2023-02-27 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 7 k | 11,41 | 82 k USD |
| 2023-02-27 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 2 k | 11,41 | 26 k USD |
| 2023-02-27 | MCCOURT Thomas A | Chief Executive Officer | Sell | 26 k | 11,41 | 292 k USD |
| 2023-02-27 | MCCOURT Thomas A | Chief Executive Officer | Sell | 4 k | 11,41 | 50 k USD |
| 2023-02-27 | Rickard Jason | SVP, Chief Operating Officer | Sell | 13 k | 11,41 | 153 k USD |
| 2023-02-27 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 11,41 | 38 k USD |
| 2023-02-27 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 11,41 | 33 k USD |
| 2023-02-27 | John Minardo | Chief Legal Officer | Sell | 3 k | 11,41 | 37 k USD |
| 2023-02-27 | MCCOURT Thomas A | Chief Executive Officer | Sell | 26 k | 11,41 | 292 k USD |
| 2023-02-27 | MCCOURT Thomas A | Chief Executive Officer | Sell | 4 k | 11,41 | 50 k USD |
| 2023-02-27 | Rickard Jason | SVP, Chief Operating Officer | Sell | 13 k | 11,41 | 153 k USD |
| 2023-02-27 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 11,41 | 38 k USD |
| 2023-02-27 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 7 k | 11,41 | 82 k USD |
| 2023-02-27 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 2 k | 11,41 | 26 k USD |
| 2023-02-27 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 11,41 | 33 k USD |
| 2023-01-17 | MCCOURT Thomas A | Chief Executive Officer | Buy | 30 k | 0,00 | 0 USD |
| 2023-01-17 | Rickard Jason | SVP, Chief Operating Officer | Buy | 18 k | 0,00 | 0 USD |
| 2023-01-17 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 15 k | 0,00 | 0 USD |
| 2023-01-17 | MCCOURT Thomas A | Chief Executive Officer | Buy | 30 k | 0,00 | 0 USD |
| 2023-01-17 | Rickard Jason | SVP, Chief Operating Officer | Buy | 18 k | 0,00 | 0 USD |
| 2023-01-17 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 15 k | 0,00 | 0 USD |
| 2023-01-05 | MCCOURT Thomas A | Chief Executive Officer | Buy | 111 k | 11,65 | 1.3 mn USD |
| 2023-01-05 | MCCOURT Thomas A | Chief Executive Officer | Sell | 111 k | 12,07 | 1.3 mn USD |
| 2023-01-05 | MCCOURT Thomas A | Chief Executive Officer | Buy | 111 k | 11,65 | 1.3 mn USD |
| 2023-01-05 | MCCOURT Thomas A | Chief Executive Officer | Sell | 111 k | 12,07 | 1.3 mn USD |
| 2022-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-12-14 | Rickard Jason | SVP, Chief Operating Officer | Sell | 27 k | 12,39 | 335 k USD |
| 2022-12-14 | Rickard Jason | SVP, Chief Operating Officer | Sell | 27 k | 12,39 | 335 k USD |
| 2022-11-21 | Davis Andrew | SVP, Chief Business Officer | Sell | 3 k | 11,56 | 39 k USD |
| 2022-11-21 | Emany Sravan Kumar | SVP, Chief Financial Officer | Sell | 7 k | 11,56 | 76 k USD |
| 2022-11-21 | Davis Andrew | SVP, Chief Business Officer | Sell | 3 k | 11,56 | 39 k USD |
| 2022-11-21 | Emany Sravan Kumar | SVP, Chief Financial Officer | Sell | 7 k | 11,56 | 76 k USD |
| 2022-11-21 | Silver Ronald | Principal Accounting Officer | Sell | 682 | 11,56 | 8 k USD |
| 2022-11-21 | Silver Ronald | Principal Accounting Officer | Sell | 682 | 11,56 | 8 k USD |
| 2022-10-03 | MCCOURT Thomas A | Chief Executive Officer | Sell | 19 k | 10,41 | 197 k USD |
| 2022-10-03 | MCCOURT Thomas A | Chief Executive Officer | Sell | 19 k | 10,41 | 197 k USD |
| 2022-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-09-01 | MCCOURT Thomas A | Chief Executive Officer | Sell | 26 k | 10,65 | 282 k USD |
| 2022-09-01 | MCCOURT Thomas A | Chief Executive Officer | Sell | 26 k | 10,65 | 282 k USD |
| 2022-08-15 | John Minardo | Chief Legal Officer | Sell | 7 k | 11,77 | 86 k USD |
| 2022-08-15 | Rickard Jason | SVP, Chief Operating Officer | Sell | 994 | 11,77 | 12 k USD |
| 2022-08-15 | Silver Ronald | Principal Accounting Officer | Sell | 2 k | 11,77 | 24 k USD |
| 2022-08-15 | John Minardo | Chief Legal Officer | Sell | 7 k | 11,77 | 86 k USD |
| 2022-08-15 | Rickard Jason | SVP, Chief Operating Officer | Sell | 994 | 11,77 | 12 k USD |
| 2022-08-15 | Silver Ronald | Principal Accounting Officer | Sell | 2 k | 11,77 | 24 k USD |
| 2022-08-11 | Currie Mark G | Director | Sell | 70 k | 11,78 | 825 k USD |
| 2022-08-11 | Currie Mark G | Director | Sell | 70 k | 11,78 | 825 k USD |
| 2022-08-09 | Rickard Jason | SVP, Chief Operating Officer | Buy | 18 k | 11,65 | 210 k USD |
| 2022-08-09 | Rickard Jason | SVP, Chief Operating Officer | Sell | 18 k | 11,75 | 212 k USD |
| 2022-08-09 | Rickard Jason | SVP, Chief Operating Officer | Buy | 18 k | 11,65 | 210 k USD |
| 2022-08-09 | Rickard Jason | SVP, Chief Operating Officer | Sell | 18 k | 11,75 | 212 k USD |
| 2022-08-08 | Rickard Jason | SVP, Chief Operating Officer | Sell | 27 k | 11,64 | 317 k USD |
| 2022-08-08 | Rickard Jason | SVP, Chief Operating Officer | Sell | 2 k | 11,56 | 26 k USD |
| 2022-08-08 | Rickard Jason | SVP, Chief Operating Officer | Sell | 27 k | 11,64 | 317 k USD |
| 2022-08-08 | Rickard Jason | SVP, Chief Operating Officer | Sell | 2 k | 11,56 | 26 k USD |
| 2022-08-01 | MCCOURT Thomas A | Chief Executive Officer | Sell | 23 k | 11,35 | 264 k USD |
| 2022-08-01 | MCCOURT Thomas A | Chief Executive Officer | Sell | 23 k | 11,35 | 264 k USD |
| 2022-06-30 | MCCOURT Thomas A | Chief Executive Officer | Sell | 20 k | 11,58 | 231 k USD |
| 2022-06-30 | MCCOURT Thomas A | Chief Executive Officer | Sell | 20 k | 11,58 | 231 k USD |
| 2022-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-06-14 | Kessler Marla L | Director | Sell | 8 k | 11,65 | 89 k USD |
| 2022-06-14 | Kessler Marla L | Director | Sell | 8 k | 11,65 | 89 k USD |
| 2022-06-07 | Currie Mark G | Director | Buy | 190 k | 11,65 | 2.2 mn USD |
| 2022-06-07 | Currie Mark G | Director | Sell | 190 k | 12,01 | 2.3 mn USD |
| 2022-06-07 | Currie Mark G | Director | Buy | 190 k | 11,65 | 2.2 mn USD |
| 2022-06-07 | Currie Mark G | Director | Sell | 190 k | 12,01 | 2.3 mn USD |
| 2022-06-01 | Currie Mark G | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | DENNER ALEXANDER J | Director, 10% owner | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Dreyfus Andrew | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Duane Jon R | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Dreyfus Andrew | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Kessler Marla L | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Moukheibir Catherine | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | McHugh Julie | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | DENNER ALEXANDER J | Director, 10% owner | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Duane Jon R | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Shepard Jay | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Currie Mark G | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Kessler Marla L | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | McHugh Julie | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Moukheibir Catherine | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | DENNER ALEXANDER J | Director, 10% owner | Buy | 22 k | 0,00 | 0 USD |
| 2022-06-01 | Shepard Jay | Director | Buy | 22 k | 0,00 | 0 USD |
| 2022-05-23 | Rickard Jason | SVP, Chief Operating Officer | Sell | 777 | 11,50 | 9 k USD |
| 2022-05-23 | Rickard Jason | SVP, Chief Operating Officer | Sell | 13 k | 11,50 | 147 k USD |
| 2022-05-23 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 3 k | 11,50 | 36 k USD |
| 2022-05-23 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 7 k | 11,50 | 86 k USD |
| 2022-05-23 | Silver Ronald | Principal Accounting Officer | Sell | 120 | 11,50 | 1 k USD |
| 2022-05-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 3 k | 11,50 | 30 k USD |
| 2022-05-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 22 k | 11,50 | 252 k USD |
| 2022-05-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 12 k | 11,50 | 136 k USD |
| 2022-05-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 3 k | 11,50 | 30 k USD |
| 2022-05-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 22 k | 11,50 | 252 k USD |
| 2022-05-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 12 k | 11,50 | 136 k USD |
| 2022-05-23 | Rickard Jason | SVP, Chief Operating Officer | Sell | 777 | 11,50 | 9 k USD |
| 2022-05-23 | Rickard Jason | SVP, Chief Operating Officer | Sell | 13 k | 11,50 | 147 k USD |
| 2022-05-23 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 3 k | 11,50 | 36 k USD |
| 2022-05-23 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 7 k | 11,50 | 86 k USD |
| 2022-05-23 | Silver Ronald | Principal Accounting Officer | Sell | 120 | 11,50 | 1 k USD |
| 2022-03-24 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 12,75 | 39 k USD |
| 2022-03-24 | Silver Ronald | Principal Accounting Officer | Sell | 3 k | 12,75 | 39 k USD |
| 2022-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-03-15 | Moukheibir Catherine | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-03-15 | Moukheibir Catherine | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2022-03-14 | McHugh Julie | Director | Sell | 20 k | 11,67 | 233 k USD |
| 2022-03-14 | McHugh Julie | Director | Sell | 20 k | 11,67 | 233 k USD |
| 2022-03-08 | MCCOURT Thomas A | Chief Executive Officer | Buy | 249 k | 0,00 | 0 USD |
| 2022-03-08 | MCCOURT Thomas A | Chief Executive Officer | Buy | 249 k | 0,00 | 0 USD |
| 2022-03-02 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 81 k | 0,00 | 0 USD |
| 2022-03-02 | John Minardo | Chief Legal Officer | Buy | 68 k | 0,00 | 0 USD |
| 2022-03-02 | Rickard Jason | SVP, Chief Operating Officer | Buy | 90 k | 0,00 | 0 USD |
| 2022-03-02 | Silver Ronald | Principal Accounting Officer | Buy | 17 k | 0,00 | 0 USD |
| 2022-03-02 | Silver Ronald | Principal Accounting Officer | Buy | 30 k | 0,00 | 0 USD |
| 2022-03-02 | John Minardo | Chief Legal Officer | Buy | 68 k | 0,00 | 0 USD |
| 2022-03-02 | Rickard Jason | SVP, Chief Operating Officer | Buy | 90 k | 0,00 | 0 USD |
| 2022-03-02 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 81 k | 0,00 | 0 USD |
| 2022-03-02 | Silver Ronald | Principal Accounting Officer | Buy | 17 k | 0,00 | 0 USD |
| 2022-03-02 | Silver Ronald | Principal Accounting Officer | Buy | 30 k | 0,00 | 0 USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 2 k | 10,77 | 21 k USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 10,77 | 34 k USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 6 k | 10,77 | 65 k USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 11 k | 10,77 | 119 k USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 7 k | 10,77 | 73 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 1 k | 10,77 | 15 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 3 k | 10,77 | 31 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 5 k | 10,77 | 56 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 4 k | 10,77 | 41 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 4 k | 10,77 | 47 k USD |
| 2022-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 2 k | 10,77 | 21 k USD |
| 2022-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 10 k | 10,77 | 108 k USD |
| 2022-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 20 k | 10,77 | 215 k USD |
| 2022-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 16 k | 10,77 | 178 k USD |
| 2022-02-28 | Silver Ronald | Principal Accounting Officer | Sell | 448 | 10,77 | 5 k USD |
| 2022-02-28 | Silver Ronald | Principal Accounting Officer | Sell | 640 | 10,77 | 7 k USD |
| 2022-02-28 | Silver Ronald | Principal Accounting Officer | Sell | 1 k | 10,77 | 12 k USD |
| 2022-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 2 k | 10,77 | 21 k USD |
| 2022-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 10 k | 10,77 | 108 k USD |
| 2022-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 20 k | 10,77 | 215 k USD |
| 2022-02-28 | MCCOURT Thomas A | Chief Executive Officer | Sell | 16 k | 10,77 | 178 k USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 2 k | 10,77 | 21 k USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 10,77 | 34 k USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 6 k | 10,77 | 65 k USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 11 k | 10,77 | 119 k USD |
| 2022-02-28 | Rickard Jason | SVP, Chief Operating Officer | Sell | 7 k | 10,77 | 73 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 1 k | 10,77 | 15 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 3 k | 10,77 | 31 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 5 k | 10,77 | 56 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 4 k | 10,77 | 41 k USD |
| 2022-02-28 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 4 k | 10,77 | 47 k USD |
| 2022-02-28 | Silver Ronald | Principal Accounting Officer | Sell | 448 | 10,77 | 5 k USD |
| 2022-02-28 | Silver Ronald | Principal Accounting Officer | Sell | 640 | 10,77 | 7 k USD |
| 2022-02-28 | Silver Ronald | Principal Accounting Officer | Sell | 1 k | 10,77 | 12 k USD |
| 2022-01-19 | MCCOURT Thomas A | Chief Executive Officer | Buy | 60 k | 0,00 | 0 USD |
| 2022-01-19 | Rickard Jason | SVP, Chief Operating Officer | Buy | 36 k | 0,00 | 0 USD |
| 2022-01-19 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 29 k | 0,00 | 0 USD |
| 2022-01-19 | MCCOURT Thomas A | Chief Executive Officer | Buy | 60 k | 0,00 | 0 USD |
| 2022-01-19 | Rickard Jason | SVP, Chief Operating Officer | Buy | 36 k | 0,00 | 0 USD |
| 2022-01-19 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Buy | 29 k | 0,00 | 0 USD |
| 2021-12-22 | MCCOURT Thomas A | Chief Executive Officer | Sell | 46 k | 11,41 | 529 k USD |
| 2021-12-22 | MCCOURT Thomas A | Chief Executive Officer | Sell | 46 k | 11,41 | 529 k USD |
| 2021-12-16 | Rickard Jason | SVP, Chief Operating Officer | Sell | 27 k | 11,28 | 305 k USD |
| 2021-12-16 | Rickard Jason | SVP, Chief Operating Officer | Sell | 27 k | 11,28 | 305 k USD |
| 2021-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-12-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-12-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-12-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-12-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-12-14 | McHugh Julie | Director | Sell | 10 k | 11,02 | 110 k USD |
| 2021-12-14 | McHugh Julie | Director | Sell | 10 k | 11,02 | 110 k USD |
| 2021-12-06 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 85 k | 0,00 | 0 USD |
| 2021-12-06 | Emany Sravan Kumar | SVP, Chief Financial Officer | Buy | 85 k | 0,00 | 0 USD |
| 2021-11-23 | Silver Ronald | Principal Accounting Officer | Sell | 749 | 11,58 | 9 k USD |
| 2021-11-23 | Silver Ronald | Principal Accounting Officer | Sell | 713 | 11,58 | 8 k USD |
| 2021-11-23 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 14 k | 11,58 | 160 k USD |
| 2021-11-23 | Rickard Jason | SVP, Chief Operating Officer | Sell | 427 | 11,58 | 5 k USD |
| 2021-11-23 | Rickard Jason | SVP, Chief Operating Officer | Sell | 17 k | 11,58 | 194 k USD |
| 2021-11-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 53 k | 11,58 | 610 k USD |
| 2021-11-23 | MCCOURT Thomas A | Chief Executive Officer | Sell | 53 k | 11,58 | 610 k USD |
| 2021-11-23 | Rickard Jason | SVP, Chief Operating Officer | Sell | 427 | 11,58 | 5 k USD |
| 2021-11-23 | Rickard Jason | SVP, Chief Operating Officer | Sell | 17 k | 11,58 | 194 k USD |
| 2021-11-23 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Sell | 14 k | 11,58 | 160 k USD |
| 2021-11-23 | Silver Ronald | Principal Accounting Officer | Sell | 749 | 11,58 | 9 k USD |
| 2021-11-23 | Silver Ronald | Principal Accounting Officer | Sell | 713 | 11,58 | 8 k USD |
| 2021-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-09-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-09-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-09-15 | Moukheibir Catherine | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-09-15 | Moukheibir Catherine | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-09-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-08-16 | Rickard Jason | SVP, Chief Operating Officer | Sell | 680 | 13,48 | 9 k USD |
| 2021-08-16 | Rickard Jason | SVP, Chief Operating Officer | Sell | 680 | 13,48 | 9 k USD |
| 2021-08-16 | Silver Ronald | Principal Accounting Officer | Sell | 567 | 13,48 | 8 k USD |
| 2021-08-02 | John Minardo | Chief Legal Officer | Buy | 80 k | 0,00 | 0 USD |
| 2021-08-02 | John Minardo | Chief Legal Officer | Buy | 80 k | 0,00 | 0 USD |
| 2021-07-20 | Silver Ronald | Principal Accounting Officer | Buy | 20 k | 0,00 | 0 USD |
| 2021-07-20 | Silver Ronald | Principal Accounting Officer | Buy | 20 k | 0,00 | 0 USD |
| 2021-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-06-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-06-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-06-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-06-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-06-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-06-14 | Currie Mark G | Director | Sell | 24 k | 11,59 | 273 k USD |
| 2021-06-14 | Currie Mark G | Director | Sell | 24 k | 11,59 | 273 k USD |
| 2021-06-07 | MCCOURT Thomas A | Chief Executive Officer | Buy | 105 k | 0,00 | 0 USD |
| 2021-06-07 | MCCOURT Thomas A | Chief Executive Officer | Buy | 105 k | 0,00 | 0 USD |
| 2021-06-02 | Currie Mark G | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | DENNER ALEXANDER J | Director, 10% owner | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Dreyfus Andrew | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Duane Jon R | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Currie Mark G | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | DENNER ALEXANDER J | Director, 10% owner | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Dreyfus Andrew | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Duane Jon R | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Kessler Marla L | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | McHugh Julie | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Moukheibir Catherine | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | OLANOFF LAWRENCE S | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Owens Edward P | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Shepard Jay | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Kessler Marla L | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | McHugh Julie | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Moukheibir Catherine | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | OLANOFF LAWRENCE S | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Owens Edward P | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | DENNER ALEXANDER J | Director, 10% owner | Buy | 23 k | 0,00 | 0 USD |
| 2021-06-02 | Shepard Jay | Director | Buy | 23 k | 0,00 | 0 USD |
| 2021-05-24 | MCCOURT Thomas A | President and Interim CEO | Sell | 2 k | 12,25 | 21 k USD |
| 2021-05-24 | Rickard Jason | SVP, Chief Operating Officer | Sell | 516 | 12,25 | 6 k USD |
| 2021-05-24 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Sell | 2 k | 12,25 | 25 k USD |
| 2021-05-24 | MCCOURT Thomas A | President and Interim CEO | Sell | 2 k | 12,25 | 21 k USD |
| 2021-05-24 | Rickard Jason | SVP, Chief Operating Officer | Sell | 516 | 12,25 | 6 k USD |
| 2021-05-24 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Sell | 2 k | 12,25 | 25 k USD |
| 2021-04-20 | McHugh Julie | Director | Buy | 3 k | 0,00 | 0 USD |
| 2021-04-20 | McHugh Julie | Director | Buy | 3 k | 0,00 | 0 USD |
| 2021-03-26 | Consylman Gina | SVP, CFO & Treasurer | Buy | 56 k | 0,00 | 0 USD |
| 2021-03-26 | Consylman Gina | SVP, CFO & Treasurer | Buy | 56 k | 0,00 | 0 USD |
| 2021-03-26 | MCCOURT Thomas A | President and Interim CEO | Buy | 97 k | 0,00 | 0 USD |
| 2021-03-26 | Rickard Jason | SVP, Chief Operating Officer | Buy | 56 k | 0,00 | 0 USD |
| 2021-03-26 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Buy | 39 k | 0,00 | 0 USD |
| 2021-03-26 | MCCOURT Thomas A | President and Interim CEO | Buy | 97 k | 0,00 | 0 USD |
| 2021-03-26 | Rickard Jason | SVP, Chief Operating Officer | Buy | 56 k | 0,00 | 0 USD |
| 2021-03-26 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Buy | 39 k | 0,00 | 0 USD |
| 2021-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-03-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-03-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-03-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2021-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-03-15 | Moukheibir Catherine | Director | Buy | 2 k | 0,00 | 0 USD |
| 2021-03-15 | DENNER ALEXANDER J | Director, 10% owner | Buy | 1 k | 0,00 | 0 USD |
| 2021-03-10 | DENNER ALEXANDER J | Director, 10% owner | Buy | 75 k | 10,54 | 790 k USD |
| 2021-03-10 | DENNER ALEXANDER J | Director, 10% owner | Buy | 75 k | 10,54 | 790 k USD |
| 2021-03-10 | DENNER ALEXANDER J | Director, 10% owner | Buy | 75 k | 10,54 | 790 k USD |
| 2021-03-08 | DENNER ALEXANDER J | Director, 10% owner | Buy | 150 k | 10,30 | 1.5 mn USD |
| 2021-03-08 | DENNER ALEXANDER J | Director, 10% owner | Buy | 150 k | 10,30 | 1.5 mn USD |
| 2021-03-08 | DENNER ALEXANDER J | Director, 10% owner | Buy | 150 k | 10,30 | 1.5 mn USD |
| 2021-03-05 | DENNER ALEXANDER J | Director, 10% owner | Buy | 175 k | 10,01 | 1.8 mn USD |
| 2021-03-05 | DENNER ALEXANDER J | Director, 10% owner | Buy | 175 k | 10,01 | 1.8 mn USD |
| 2021-03-05 | DENNER ALEXANDER J | Director, 10% owner | Buy | 175 k | 10,01 | 1.8 mn USD |
| 2021-03-04 | DENNER ALEXANDER J | Director, 10% owner | Buy | 250 k | 10,00 | 2.5 mn USD |
| 2021-03-04 | DENNER ALEXANDER J | Director, 10% owner | Buy | 250 k | 10,00 | 2.5 mn USD |
| 2021-03-04 | DENNER ALEXANDER J | Director, 10% owner | Buy | 250 k | 10,00 | 2.5 mn USD |
| 2021-03-03 | DENNER ALEXANDER J | Director, 10% owner | Buy | 350 k | 10,02 | 3.5 mn USD |
| 2021-03-03 | DENNER ALEXANDER J | Director, 10% owner | Buy | 350 k | 10,02 | 3.5 mn USD |
| 2021-03-03 | DENNER ALEXANDER J | Director, 10% owner | Buy | 350 k | 10,02 | 3.5 mn USD |
| 2021-03-02 | DENNER ALEXANDER J | Director | Buy | 500 k | 9,56 | 4.8 mn USD |
| 2021-03-02 | DENNER ALEXANDER J | Director | Buy | 500 k | 9,56 | 4.8 mn USD |
| 2021-03-01 | DENNER ALEXANDER J | Director | Buy | 345 k | 9,60 | 3.3 mn USD |
| 2021-03-01 | DENNER ALEXANDER J | Director | Buy | 345 k | 9,60 | 3.3 mn USD |
| 2021-02-26 | Consylman Gina | SVP, CFO & Treasurer | Sell | 3 k | 9,11 | 24 k USD |
| 2021-02-26 | Consylman Gina | SVP, CFO & Treasurer | Sell | 3 k | 9,11 | 23 k USD |
| 2021-02-26 | Consylman Gina | SVP, CFO & Treasurer | Sell | 6 k | 9,11 | 57 k USD |
| 2021-02-26 | Consylman Gina | SVP, CFO & Treasurer | Sell | 7 k | 9,11 | 64 k USD |
| 2021-02-26 | DENNER ALEXANDER J | Director | Buy | 505 k | 9,20 | 4.6 mn USD |
| 2021-02-26 | Consylman Gina | SVP, CFO & Treasurer | Sell | 3 k | 9,11 | 24 k USD |
| 2021-02-26 | Consylman Gina | SVP, CFO & Treasurer | Sell | 3 k | 9,11 | 23 k USD |
| 2021-02-26 | Consylman Gina | SVP, CFO & Treasurer | Sell | 6 k | 9,11 | 57 k USD |
| 2021-02-26 | Consylman Gina | SVP, CFO & Treasurer | Sell | 7 k | 9,11 | 64 k USD |
| 2021-02-26 | Kilroy Conor | SVP, GC & Secretary | Sell | 1 k | 9,11 | 13 k USD |
| 2021-02-26 | Kilroy Conor | SVP, GC & Secretary | Sell | 1 k | 9,11 | 13 k USD |
| 2021-02-26 | Kilroy Conor | SVP, GC & Secretary | Sell | 2 k | 9,11 | 21 k USD |
| 2021-02-26 | Kilroy Conor | SVP, GC & Secretary | Sell | 2 k | 9,11 | 17 k USD |
| 2021-02-26 | Mallon Mark | Chief Executive Officer | Sell | 8 k | 9,11 | 74 k USD |
| 2021-02-26 | Mallon Mark | Chief Executive Officer | Sell | 23 k | 9,11 | 206 k USD |
| 2021-02-26 | MCCOURT Thomas A | President | Sell | 3 k | 9,11 | 24 k USD |
| 2021-02-26 | MCCOURT Thomas A | President | Sell | 2 k | 9,11 | 17 k USD |
| 2021-02-26 | MCCOURT Thomas A | President | Sell | 10 k | 9,11 | 94 k USD |
| 2021-02-26 | Owens Edward P | Director | Buy | 3 k | 8,90 | 27 k USD |
| 2021-02-26 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 9,11 | 24 k USD |
| 2021-02-26 | Rickard Jason | SVP, Chief Operating Officer | Sell | 2 k | 9,11 | 15 k USD |
| 2021-02-26 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 9,11 | 29 k USD |
| 2021-02-26 | Rickard Jason | SVP, Chief Operating Officer | Sell | 6 k | 9,11 | 56 k USD |
| 2021-02-26 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Sell | 1 k | 9,11 | 13 k USD |
| 2021-02-26 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Sell | 3 k | 9,11 | 28 k USD |
| 2021-02-26 | DENNER ALEXANDER J | Director | Buy | 505 k | 9,20 | 4.6 mn USD |
| 2021-02-26 | Kilroy Conor | SVP, GC & Secretary | Sell | 1 k | 9,11 | 13 k USD |
| 2021-02-26 | Kilroy Conor | SVP, GC & Secretary | Sell | 1 k | 9,11 | 13 k USD |
| 2021-02-26 | Kilroy Conor | SVP, GC & Secretary | Sell | 2 k | 9,11 | 21 k USD |
| 2021-02-26 | Kilroy Conor | SVP, GC & Secretary | Sell | 2 k | 9,11 | 17 k USD |
| 2021-02-26 | MCCOURT Thomas A | President | Sell | 3 k | 9,11 | 24 k USD |
| 2021-02-26 | MCCOURT Thomas A | President | Sell | 2 k | 9,11 | 17 k USD |
| 2021-02-26 | MCCOURT Thomas A | President | Sell | 10 k | 9,11 | 94 k USD |
| 2021-02-26 | Mallon Mark | Chief Executive Officer | Sell | 8 k | 9,11 | 74 k USD |
| 2021-02-26 | Mallon Mark | Chief Executive Officer | Sell | 23 k | 9,11 | 206 k USD |
| 2021-02-26 | Owens Edward P | Director | Buy | 3 k | 8,90 | 27 k USD |
| 2021-02-26 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 9,11 | 24 k USD |
| 2021-02-26 | Rickard Jason | SVP, Chief Operating Officer | Sell | 2 k | 9,11 | 15 k USD |
| 2021-02-26 | Rickard Jason | SVP, Chief Operating Officer | Sell | 3 k | 9,11 | 29 k USD |
| 2021-02-26 | Rickard Jason | SVP, Chief Operating Officer | Sell | 6 k | 9,11 | 56 k USD |
| 2021-02-26 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Sell | 1 k | 9,11 | 13 k USD |
| 2021-02-26 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Sell | 3 k | 9,11 | 28 k USD |
| 2021-02-25 | Owens Edward P | Director | Buy | 5 k | 9,11 | 46 k USD |
| 2021-02-25 | Owens Edward P | Director | Buy | 5 k | 9,11 | 46 k USD |
| 2021-02-24 | Owens Edward P | Director | Buy | 7 k | 9,26 | 65 k USD |
| 2021-02-24 | Owens Edward P | Director | Buy | 7 k | 9,26 | 65 k USD |
| 2021-02-22 | Consylman Gina | SVP, CFO & Treasurer | Buy | 85 k | 0,00 | 0 USD |
| 2021-02-22 | Consylman Gina | SVP, CFO & Treasurer | Buy | 85 k | 0,00 | 0 USD |
| 2021-02-22 | MCCOURT Thomas A | President | Buy | 146 k | 0,00 | 0 USD |
| 2021-02-22 | Rickard Jason | SVP, Chief Operating Officer | Buy | 85 k | 0,00 | 0 USD |
| 2021-02-22 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Buy | 58 k | 0,00 | 0 USD |
| 2021-02-22 | MCCOURT Thomas A | President | Buy | 146 k | 0,00 | 0 USD |
| 2021-02-22 | Rickard Jason | SVP, Chief Operating Officer | Buy | 85 k | 0,00 | 0 USD |
| 2021-02-22 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Buy | 58 k | 0,00 | 0 USD |
| 2020-12-15 | DENNER ALEXANDER J | Director | Buy | 661 | 0,00 | 0 USD |
| 2020-12-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2020-12-15 | DENNER ALEXANDER J | Director | Buy | 661 | 0,00 | 0 USD |
| 2020-12-15 | Dreyfus Andrew | Director | Buy | 1 k | 0,00 | 0 USD |
| 2020-12-14 | MCCOURT Thomas A | President | Buy | 100 k | 9,89 | 989 k USD |
| 2020-12-14 | MCCOURT Thomas A | President | Sell | 81 k | 12,20 | 989 k USD |
| 2020-12-14 | MCCOURT Thomas A | President | Buy | 100 k | 9,89 | 989 k USD |
| 2020-12-14 | MCCOURT Thomas A | President | Sell | 81 k | 12,20 | 989 k USD |
| 2020-12-04 | MacDonald Kelly | Chief Accounting Officer | Buy | 6 k | 9,12 | 51 k USD |
| 2020-12-04 | MacDonald Kelly | Chief Accounting Officer | Sell | 6 k | 12,50 | 70 k USD |
| 2020-12-04 | MacDonald Kelly | Chief Accounting Officer | Buy | 6 k | 9,12 | 51 k USD |
| 2020-12-04 | MacDonald Kelly | Chief Accounting Officer | Sell | 6 k | 12,50 | 70 k USD |
| 2020-12-03 | Shepard Jay | Director | Buy | 25 k | 0,00 | 0 USD |
| 2020-12-03 | Shepard Jay | Director | Buy | 11 k | 0,00 | 0 USD |
| 2020-12-03 | Shepard Jay | Director | Buy | 25 k | 0,00 | 0 USD |
| 2020-12-03 | Shepard Jay | Director | Buy | 11 k | 0,00 | 0 USD |
| 2020-11-11 | MacDonald Kelly | Chief Accounting Officer | Buy | 4 k | 9,31 | 33 k USD |
| 2020-11-11 | MacDonald Kelly | Chief Accounting Officer | Sell | 4 k | 11,75 | 42 k USD |
| 2020-11-11 | MacDonald Kelly | Chief Accounting Officer | Buy | 4 k | 9,31 | 33 k USD |
| 2020-11-11 | MacDonald Kelly | Chief Accounting Officer | Sell | 4 k | 11,75 | 42 k USD |
| 2020-11-09 | Consylman Gina | SVP, CFO & Treasurer | Sell | 825 | 10,92 | 9 k USD |
| 2020-11-09 | Consylman Gina | SVP, CFO & Treasurer | Sell | 590 | 10,92 | 6 k USD |
| 2020-11-09 | Consylman Gina | SVP, CFO & Treasurer | Sell | 825 | 10,92 | 9 k USD |
| 2020-11-09 | Consylman Gina | SVP, CFO & Treasurer | Sell | 590 | 10,92 | 6 k USD |
| 2020-11-09 | Kilroy Conor | SVP, GC & Secretary | Sell | 599 | 10,92 | 7 k USD |
| 2020-11-09 | Kilroy Conor | SVP, GC & Secretary | Sell | 237 | 10,92 | 3 k USD |
| 2020-11-09 | MacDonald Kelly | Chief Accounting Officer | Sell | 825 | 10,92 | 9 k USD |
| 2020-11-09 | MacDonald Kelly | Chief Accounting Officer | Sell | 100 | 10,92 | 1 k USD |
| 2020-11-09 | Rickard Jason | SVP, Chief Operating Officer | Sell | 394 | 10,92 | 4 k USD |
| 2020-11-09 | Kilroy Conor | SVP, GC & Secretary | Sell | 599 | 10,92 | 7 k USD |
| 2020-11-09 | Kilroy Conor | SVP, GC & Secretary | Sell | 237 | 10,92 | 3 k USD |
| 2020-11-09 | MacDonald Kelly | Chief Accounting Officer | Sell | 825 | 10,92 | 9 k USD |
| 2020-11-09 | MacDonald Kelly | Chief Accounting Officer | Sell | 100 | 10,92 | 1 k USD |
| 2020-11-09 | Rickard Jason | SVP, Chief Operating Officer | Sell | 394 | 10,92 | 4 k USD |
| 2020-11-09 | DENNER ALEXANDER J | Director | Buy | 12 k | 0,00 | 0 USD |
| 2020-11-09 | DENNER ALEXANDER J | Director | Buy | 25 k | 0,00 | 0 USD |
| 2020-11-09 | DENNER ALEXANDER J | Director | Buy | 12 k | 0,00 | 0 USD |
| 2020-11-09 | DENNER ALEXANDER J | Director | Buy | 25 k | 0,00 | 0 USD |
| 2020-11-06 | MacDonald Kelly | Chief Accounting Officer | Sell | 2 k | 11,25 | 21 k USD |
| 2020-11-06 | MacDonald Kelly | Chief Accounting Officer | Sell | 2 k | 11,25 | 21 k USD |
| 2020-10-08 | MacDonald Kelly | Chief Accounting Officer | Sell | 23 k | 10,50 | 238 k USD |
| 2020-10-08 | MacDonald Kelly | Chief Accounting Officer | Sell | 23 k | 10,50 | 238 k USD |
| 2020-09-15 | Dreyfus Andrew | Director | Buy | 2 k | 0,00 | 0 USD |
| 2020-09-15 | Dreyfus Andrew | Director | Buy | 2 k | 0,00 | 0 USD |
| 2020-09-08 | McHugh Julie | Director | Sell | 8 k | 9,77 | 78 k USD |
| 2020-09-08 | McHugh Julie | Director | Sell | 8 k | 9,77 | 78 k USD |
| 2020-08-17 | MacDonald Kelly | Chief Accounting Officer | Sell | 575 | 10,14 | 6 k USD |
| 2020-08-17 | Rickard Jason | SVP, Chief Operating Officer | Sell | 689 | 10,14 | 7 k USD |
| 2020-08-17 | MacDonald Kelly | Chief Accounting Officer | Sell | 575 | 10,14 | 6 k USD |
| 2020-08-17 | Rickard Jason | SVP, Chief Operating Officer | Sell | 689 | 10,14 | 7 k USD |

